COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status.
作者信息
Butt Adeel A, Dargham Soha R, Coyle Peter, Yassine Hadi M, Al-Khal Abdullatif, Abou-Samra Abdul-Badi, Abu-Raddad Laith J
机构信息
Hamad Medical Corporation, Doha, Qatar.
Department of Medicine, Weill Cornell Medicine, New York, New York.
出版信息
JAMA Intern Med. 2022 Oct 1;182(10):1097-1099. doi: 10.1001/jamainternmed.2022.3351.
Abstract
摘要
相似文献
1
COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status.感染奥密克戎BA.1和BA.2亚谱系的COVID-19患者的疾病严重程度及其与疫苗接种状况的关联。
JAMA Intern Med. 2022 Oct 1;182(10):1097-1099. doi: 10.1001/jamainternmed.2022.3351.
2
Significant neutralizing escapes of Omicron and its sublineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines.在接种灭活疫苗的 SARS-CoV-2 感染个体中，奥密克戎及其亚谱系发生了显著的中和逃逸。
J Med Virol. 2023 Feb;95(2):e28516. doi: 10.1002/jmv.28516.
3
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.奥密克戎 BA.4 和 BA.5 亚谱系流行期间，根据疫苗接种状态估计 COVID-19 mRNA 疫苗有效性和 COVID-19 疾病及严重程度。
JAMA Netw Open. 2023 Mar 1;6(3):e232598. doi: 10.1001/jamanetworkopen.2023.2598.
4
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.COVID-19 mRNA 疫苗在奥密克戎为主导期间对免疫功能低下成年人 COVID-19 相关住院的有效性- VISION 网络，10 个州，2021 年 12 月至 2022 年 8 月。
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1335-1342. doi: 10.15585/mmwr.mm7142a4.
5
Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan.在日本奥密克戎 BA.1/BA.2 和 BA.5 为主导时期，社区居民 COVID-19 患者中疫苗接种状况与严重健康后果之间的关联。
Environ Health Prev Med. 2023;28:35. doi: 10.1265/ehpm.23-00061.
6
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages.奥密克戎亚谱系的交叉中和与病毒适应性。
Emerg Microbes Infect. 2023 Dec;12(1):e2161422. doi: 10.1080/22221751.2022.2161422.
7
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.2、3 和 4 剂 COVID-19 mRNA 疫苗在 SARS-CoV-2 奥密克戎 BA.1 和 BA.2/BA.2.12.1 亚谱系占主导地位期间对免疫功能正常成年人的有效性 - VISION 网络，10 个州，2021 年 12 月至 2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):931-939. doi: 10.15585/mmwr.mm7129e1.
8
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.早期估计，二价 mRNA 加强针在预防免疫功能正常成年人因奥密克戎 BA.5-和 XBB/XBB.1.5 相关亚谱系导致的有症状 SARS-CoV-2 感染方面的有效性-增加社区获得检测计划，美国，2022 年 12 月至 2023 年 1 月。
MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1.
9
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.2022 年 5 月 2 日至 7 月 24 日，荷兰，与先前感染 BA.1 相比，再次感染奥密克戎 BA.4/5 变体的 SARS-CoV-2 风险更高。
Euro Surveill. 2023 Feb;28(7). doi: 10.2807/1560-7917.ES.2023.28.7.2200724.
10
Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.引言：2021 年 12 月，芬兰出现 SARS-CoV-2 奥密克戎变异株的引入和快速传播，以及 BA.1 和 BA.1.1 亚谱系的动态变化
Emerg Infect Dis. 2022 Jun;28(6):1229-1232. doi: 10.3201/eid2806.220515. Epub 2022 Apr 4.
引用本文的文献
1
The association between previous SARS-CoV-2 infection and incidence of stroke.既往新冠病毒感染与中风发病率之间的关联。
IJID Reg. 2025 Jul 28;16:100716. doi: 10.1016/j.ijregi.2025.100716. eCollection 2025 Sep.
2
Immune histories and natural infection protection during the omicron era.奥密克戎时代的免疫史与自然感染防护
Commun Med (Lond). 2025 Jul 1;5(1):262. doi: 10.1038/s43856-025-00974-9.
3
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar.评估医院入院数据作为新冠病毒疾病严重程度的指标：卡塔尔的一项全国性评估。
Open Forum Infect Dis. 2025 Feb 17;12(3):ofaf098. doi: 10.1093/ofid/ofaf098. eCollection 2025 Mar.
4
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar.新冠疫情期间COVID-19严重程度和死亡率的转折点：卡塔尔的一项全国队列研究
BMJ Public Health. 2023 Oct 29;1(1):e000479. doi: 10.1136/bmjph-2023-000479. eCollection 2023 Nov.
5
Estimating Excess Mortality During the COVID-19 Pandemic Between 2020-2022 in Korea.估算 2020-2022 年韩国 COVID-19 大流行期间的超额死亡率。
J Korean Med Sci. 2024 Oct 21;39(40):e267. doi: 10.3346/jkms.2024.39.e267.
6
Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States.追踪与 COVID-19 主要变异株和疫苗有效性相关的病死率和症状学的时间变化在美国。
Front Public Health. 2024 Sep 18;12:1419886. doi: 10.3389/fpubh.2024.1419886. eCollection 2024.
7
Effectiveness of Lianhua Qingwen Granule and Jingyin Gubiao Prescription in Omicron BA.2 Infection and Hospitalization: A Real-World Study of 56,244 Cases in Shanghai, China.连花清瘟颗粒与荆银固表方对奥密克戎BA.2感染及住院治疗的有效性：一项针对中国上海56244例病例的真实世界研究
Chin J Integr Med. 2025 Jan;31(1):11-18. doi: 10.1007/s11655-024-3901-7. Epub 2024 Jun 24.
8
Prognostic Factors for Predicting Post-COVID-19 Condition in Patients With COVID-19 in an Outpatient Setting.预测 COVID-19 门诊患者发生新冠后疾病的预后因素。
J Korean Med Sci. 2024 Jan 15;39(2):e23. doi: 10.3346/jkms.2024.39.e23.
9
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study.SARS-CoV-2 感染以及年龄、性别、合并症和疫苗接种对老年人的影响：一项全国队列研究。
Influenza Other Respir Viruses. 2023 Nov;17(11):e13224. doi: 10.1111/irv.13224.
10
History of primary-series and booster vaccination and protection against Omicron reinfection.初级系列和加强针接种史与奥密克戎再感染的保护作用。
Sci Adv. 2023 Oct 6;9(40):eadh0761. doi: 10.1126/sciadv.adh0761. Epub 2023 Oct 4.
Zotero 插件